| Cullman Podiatry | |
|
1985 Alabama Hwy 157, Suite A, Cullman, AL 35058 | |
| (256) 739-1912 | |
| (205) 314-8551 |
| Full Name | Cullman Podiatry |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 1985 Alabama Hwy 157, Cullman, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588705883 | NPI | - | NPPES |
| 51070700 | Other | AL | BLUE CROSS |
| 528902460 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cullman Podiatry 1985 Alabama Hwy 157, Suite A, Cullman, AL 35058 Ph: (256) 739-1912 | Cullman Podiatry 1985 Alabama Hwy 157, Suite A, Cullman, AL 35058 Ph: (256) 739-1912 |
News Archive
Cara Therapeutics, Inc. today announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center, double-blind, placebo-controlled study was conducted at eight hospitals in the United States and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted hysterectomy.
One of the major obstacles with treating cancer is that tumors can conscript the body's immune cells and make them work for them. Researchers at EPFL have now found a way to reclaim the corrupted immune cells, turn them into signals for the immune system to attack the tumor, and even prevent metastasis.
Waters Corporation today announced it signed a land-purchase agreement with The Royal Bank of Scotland for a new Mass Spectrometry Headquarters in Wilmslow, Cheshire, near Manchester, U.K.
Lixte Biotechnology Holdings announced today that the National Cancer Institute Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), signed a NExT Material Transfer Agreement formalizing a collaboration with Lixte Biotechnology Holdings, Inc. for clinical evaluation of LB-100, one of Lixte's lead anti-cancer compounds.
Children of women who took the epilepsy drug valproate during pregnancy appear to be at a greater risk for lower IQ, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.
› Verified 8 days ago
Eric B Fillinger, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 1400 Wall St, Cullman, AL 35055 Phone: 256-739-7339 Fax: 256-737-7340 | |
Dr. Robert F Ocampo, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1938 Al Highway 157 Ste 101, Cullman, AL 35058 Phone: 256-735-5505 Fax: 256-964-9954 | |
Dr. Natalie Josephine Giammanco, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1985 Al Highway 157, Suite A, Cullman, AL 35058 Phone: 256-739-1912 Fax: 205-314-8551 | |
Steven M Grunfeld, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1985 Alabama Hwy 157, Cullman, AL 35058 Phone: 256-739-1912 Fax: 256-739-8306 | |
Fillinger Foot Clinic, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1400 Wall St, Cullman, AL 35055 Phone: 256-739-7339 Fax: 256-737-7340 |